← Back to Treatments
🏅 FDA Orphan Designation

Ventavis

Iloprost inhalation solution

Manufacturer: CoTherix, Inc.

Indicated for:
Pulmonary arterial hypertensionOrphan

FDA-Approved Indications (1)

Treatment of pulmonary arterial hypertension (WHO Group I) in patients with NYHA Class III or IV symptoms

Indications & Usage

Treatment of pulmonary arterial hypertension (WHO Group I) in patients with NYHA Class III or IV symptoms

💙 Support Programs

View all →
Ventavis
CoTherix, Inc.

Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.